ENHANCED GENOMICS LIMITED
Company number 12423696 · Monitor this company
5 active · persons with significant control
Mnl (Parkwalk) Nominees Limited
Nature of control
- Owns between 25% and 50% of the company's shares
- Has between 25% and 50% of the voting rights in the company
- Notified on
- 2025-11-26
- Correspondence address
- 4th Floor, 140 Aldersgate Street, London, EC1A 4HY, United Kingdom
- Legal form
- Private Company
Bgf Investment Management Limited
Nature of control
- Owns between 25% and 50% of the company's shares
- Has between 25% and 50% of the voting rights in the company
- Notified on
- 2025-08-28
- Correspondence address
- 13-15, York Buildings, London, WC2N 6JU, United Kingdom
- Legal form
- Private Limited Company
- Place registered
- Companies House
- Registration number
- 10608481
- Country registered
- United Kingdom
Dr Mikhail Spivakov
Nature of control
- Owns between 25% and 50% of the company's shares
- Has between 25% and 50% of the voting rights in the company
- Right to appoint and remove directors
- Notified on
- 2020-01-24
- Date of birth
- April 1980
- Nationality
- British
- Country of residence
- United Kingdom
- Correspondence address
- Babraham Institute, Building 570, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
Dr Stefan Walter Schoenfelder
Nature of control
- Owns between 25% and 50% of the company's shares
- Has between 25% and 50% of the voting rights in the company
- Right to appoint and remove directors
- Notified on
- 2020-01-24
- Date of birth
- July 1973
- Nationality
- German
- Country of residence
- United Kingdom
- Correspondence address
- Babraham Institute, Building 570, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
Prof Peter John Fraser
Nature of control
- Owns between 25% and 50% of the company's shares
- Has between 25% and 50% of the voting rights in the company
- Right to appoint and remove directors
- Notified on
- 2020-01-24
- Date of birth
- May 1956
- Nationality
- American
- Country of residence
- United States
- Correspondence address
- Babraham Institute, Building 570, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom